Mortality in Patients with Rheumatoid Arthritis and Interstitial Lung Disease Treated with First Line TNFi or Rituximab Therapies

被引：0
作者：
Druce, Katie [1 ]
Iqbal, Kundan [2 ]
Watson, Kath [1 ]
Symmons, Deborah P. M. [1 ]
Hyrich, Kimmc L. [1 ]
Kelly, Clive [3 ]
机构：
[1] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[2] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
[3] Queen Elizabeth Hosp, Rheumatol, Gateshead, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3065
引用
收藏
页数：3
相关论文
共 50 条
  • [21] THE POTENT WEAPON FOR RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE : RITUXIMAB EXPERIENCES
    Karakas, Burak
    Derin, Mehmet Emin
    Albayrak, Fatih
    Sahin, Ali
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1663 - 1663
  • [22] Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients
    Riccardo Messina
    Giuliana Guggino
    Alida Benfante
    Nicola Scichilone
    [J]. Drugs & Aging, 2020, 37 : 11 - 18
  • [23] Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients
    Messina, Riccardo
    Guggino, Giuliana
    Benfante, Alida
    Scichilone, Nicola
    [J]. DRUGS & AGING, 2020, 37 (01) : 11 - 18
  • [24] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Kur-Zalewska, J.
    Raczkiewicz, A.
    Bujakowska, O.
    Juszkiewicz, A.
    Tlustochowicz, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 913 - 914
  • [25] Rituximab Efficacy in the Treatment of Diffuse Interstitial Lung Disease Associated with Rheumatoid Arthritis
    Narvaez, Javier
    Ricse, Milagros
    Jose Alegre, Juan
    Albert Espi, Gloria
    Gomez Vaquero, Carmen
    Borrell Panos, Helena
    Armengol, Eulalia
    Miquel Nolla, Joan
    Herrera, Susana
    Molina, Maria
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] RHEUMATOID ARTHRITIS ASSOCIATED INTERSTITIAL LUNG DISEASE PROGRESSION IN A COHORT OF TREATED TO TARGET PATIENTS
    Margiotta, D. P. E.
    Navarini, L.
    Basta, F.
    Lo Vullo, M.
    Vadacca, M.
    Marigliano, B.
    Pignataro, F.
    Zardi, E. M.
    Afeltra, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1007 - 1008
  • [27] EVALUATION OF MEDICATION PERSISTENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SJOGREN'S SYNDROME/INTERSTITIAL LUNG DISEASE TREATED WITH NON-TNFI DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Ferri, Leticia
    Alemao, Evo
    Rao, Aarti
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 306 - 306
  • [28] RITUXIMAB EXPERIENCE FROM A SINGLE CENTRE FOR PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE
    Eroglu, Didem Sahin
    Colaklar, Anil
    Baysal, Serdar
    Torgutalp, Murat
    Baygul, Asaf
    Yayla, Mucteba Enes
    Sezer, Serdar
    Uzun, Caglar
    Kumbasar, Ozlem Ozdemir
    Turgay, Tahsin Murat
    Kinikli, Gulay
    Ates, Askin
    [J]. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2022, 39 (03)
  • [29] SAFETY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND CONCOMITANT LUNG DISEASE
    Dass, Shouvik
    Atzeni, Fabiola
    Vital, Edward M.
    Bingham, Sarah J.
    Buch, Maya
    Beirne, Paul
    Emery, Paul
    [J]. RHEUMATOLOGY, 2011, 50 : 121 - 121
  • [30] RITUXIMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS RELATED LUNG DISEASE
    Iqbal, K.
    Kelly, C.
    Saravanan, V.
    Rynne, M.
    Hamilton, J.
    Heycock, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 385 - 385
12345